Surgery Partners, Inc. (NASDAQ:SGRY) Insider Sells $76,028.04 in Stock

Surgery Partners, Inc. (NASDAQ:SGRY) insider Marissa Brittenham sold 3,156 shares of the business’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $24.09, for a total transaction of $76,028.04. Following the completion of the sale, the insider now owns 63,408 shares of the company’s stock, valued at approximately $1,527,498.72. This represents a 4.74 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link.

Surgery Partners Trading Down 0.0 %

NASDAQ SGRY opened at $23.60 on Friday. Surgery Partners, Inc. has a 12-month low of $19.50 and a 12-month high of $33.97. The company has a fifty day simple moving average of $23.58 and a two-hundred day simple moving average of $26.04. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99. The stock has a market cap of $3.01 billion, a P/E ratio of -49.17, a P/E/G ratio of 19.21 and a beta of 2.73.

Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings results on Monday, March 3rd. The company reported $0.39 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.01. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The company had revenue of $864.40 million during the quarter, compared to analysts’ expectations of $828.09 million. On average, analysts forecast that Surgery Partners, Inc. will post 0.67 earnings per share for the current year.

Hedge Funds Weigh In On Surgery Partners

A number of institutional investors have recently bought and sold shares of the business. KBC Group NV lifted its position in Surgery Partners by 31.8% during the third quarter. KBC Group NV now owns 2,385 shares of the company’s stock valued at $77,000 after purchasing an additional 576 shares during the period. Point72 Asia Singapore Pte. Ltd. grew its holdings in Surgery Partners by 747.6% during the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company’s stock worth $124,000 after acquiring an additional 3,379 shares during the period. State of Wyoming lifted its holdings in Surgery Partners by 94.4% in the fourth quarter. State of Wyoming now owns 4,002 shares of the company’s stock valued at $85,000 after acquiring an additional 1,943 shares during the period. Versor Investments LP purchased a new stake in Surgery Partners in the 3rd quarter worth approximately $271,000. Finally, MeadowBrook Investment Advisors LLC increased its holdings in shares of Surgery Partners by 16.6% during the 4th quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company’s stock valued at $218,000 after purchasing an additional 1,460 shares in the last quarter.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the stock. JPMorgan Chase & Co. reduced their price objective on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a research note on Tuesday, December 3rd. Bank of America started coverage on shares of Surgery Partners in a research note on Monday, December 16th. They set a “buy” rating and a $30.00 price objective for the company. Royal Bank of Canada lowered their target price on shares of Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a research note on Wednesday, November 20th. Finally, Macquarie cut their price target on shares of Surgery Partners from $34.00 to $33.00 and set an “outperform” rating on the stock in a report on Tuesday, March 11th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $36.63.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.